Vicore Pharma Holding AB

NASDAQ:VCRE

Medical - Pharmaceuticals

Healthcare
$9.90 -1.66%

-$0.24 today

Market cap
$279.65M
Beta
0.15

Volume 0.00M

Average 0.26M

Income Statement

Follow revenue through to earnings.

Revenue

$3.82M

FY 2025 · Annual

-96.5% YoY

Operating Income

-$454.44M

FY 2025 · Annual

Net Income

-$477.47M

FY 2025 · Annual

Income Statement

SEK
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000109.35M3.82M
Cost of Revenue3.58M0000
Gross Profit(3.58M)00109.35M3.82M
Gross Margin———100.0%100.0%
Research & Development30.05M249.97M276.29M249.26M390.35M
Selling, General & Admin2.39M37.53M44.6M50.44M67.91M
Operating Expenses32.59M290.73M321.51M299.71M458.26M
Depreciation & Amortization371.33K3.61M3.42M2.24M0
EBITDA(32.07M)(285.19M)(307.9M)(166.64M)(477.41M)
EBITDA Margin———-152.4%-12507.6%
Operating Income(32.59M)(290.73M)(321.51M)(190.36M)(454.45M)
Operating Margin———-174.1%-11905.8%
Interest Income70.2K913K10.54M21.08M23.89M
Interest Expense08K2K8K60K
Other Income / Expenses(211.92K)1.92M10.18M21.47M(23.03M)
Income Before Tax(32.8M)(288.81M)(311.33M)(168.89M)(477.47M)
Pre-Tax Margin———-154.5%-12509.1%
Income Tax Expense(252.7K)(384K)(384K)(256K)0
Net Income(294.97M)(288.42M)(310.94M)(168.63M)(477.47M)
Net Margin———-154.2%-12509.1%
EPS (Basic)(0.47)(38.82)(31.80)(12.30)(19.90)
EPS (Diluted)(0.47)(38.82)(31.80)(12.30)(19.90)
Weighted Avg Shares69.68M7.42M9.66M13.68M23.99M
Weighted Avg Shares (Diluted)69.68M7.42M9.66M13.68M23.99M

VCRE Earnings Waterfall · TTM

NASDAQ:VCRE · Revenue to Net Income

Key Ratios

EPS$-9.40
Gross Margin100.0%
Net Margin-18037.4%
P/E Ratio-377.1
P/S Ratio163385.2

Analysis

$1.3M of revenue converted into -$272.5M of net income for the selected period. Gross margin is 100.0% and net margin is -18037.4%, showing how much revenue survives after costs and taxes. EPS is $-9.40, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingOct 22, 2026
SC 13GSC 13G filingOct 13, 2026
6-K6-K filingSep 30, 2026

How much revenue does VCRE generate?

Vicore Pharma Holding AB (VCRE) reported $3.82M of revenue in fiscal 2025.

Is VCRE profitable?

Vicore Pharma Holding AB (VCRE) reported -$477.47M of net income, with a net margin of -12509.1%.